Evidence map›Paper›PMID 31115108›Full record

ArticleXenotransplantation2019

Generation of cattle knockout for galactose-α1,3-galactose and N-glycolylneuraminic acid antigens.

Andrea Perota, Irina Lagutina, Roberto Duchi, Elisa Zanfrini, Giovanna Lazzari, Jean Paul Judor, Sophie Conchon, Jean Marie Bach, Tomaso Bottio, Gino Gerosa and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Xenotransplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Pre-clinical strategies and emerging technologies driving advances in the alpha-gal syndrome.Allergology international : official journal of the Japanese Society of Allergology · 2025
    Review
  5. Review
  6. Current Techniques of Gene Editing in Pigs for Xenotransplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  7. Revisiting aortic valve prosthesis choice in patients younger than 50 years: 10 years results of the AUTHEARTVISIT study.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Degeneration of Bioprosthetic Heart Valves: Update 2020.Journal of the American Heart Association · 2020
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Andrea PerotaAvantea, Laboratory of Reproductive Technologies, Cremona, Italy.
Irina LagutinaAvantea, Laboratory of Reproductive Technologies, Cremona, Italy.
Roberto DuchiAvantea, Laboratory of Reproductive Technologies, Cremona, Italy.
Elisa ZanfriniAvantea, Laboratory of Reproductive Technologies, Cremona, Italy.
Giovanna LazzariAvantea, Laboratory of Reproductive Technologies, Cremona, Italy.
Jean Paul JudorCentre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.
Sophie ConchonCentre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.
Jean Marie BachIECM, Immuno-endocrinology, EA4644 Oniris, University of Nantes, USC1383 INRA, Oniris, Nantes, France.
Tomaso BottioCardiac Surgery Unit - Department of Cardiac, Thoracic and Vascular Sciences and Public Health - Padova University School of Medicine and CORIS, Padova, Italy.
Gino GerosaCardiac Surgery Unit - Department of Cardiac, Thoracic and Vascular Sciences and Public Health - Padova University School of Medicine and CORIS, Padova, Italy.
Cristina CostaInfectious Diseases and Transplantation Division, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
Manuel GaliñanesReparative Therapy of the Heart, Vall d'Hebron Research Institute (VHIR) and Department of Cardiac Surgery, University Hospital Vall d'Hebron, Autonomous University of Barcelona (AUB), Barcelona, Spain.
Jean Christian RousselDepartment of Thoracic and CardioVascular Surgery, Nantes Hospital University, Nantes, France.
Vered Padler-KaravaniThe George S. Wise Faculty of Life Sciences, Department of Cell Research and Immunology, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-4761-3571
Emanuele CozziTransplant Immunology Unit, Padua General Hospital, Padua, Italy.
Jean Paul SoulillouCentre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.
Cesare GalliAvantea, Laboratory of Reproductive Technologies, Cremona, Italy.ORCID 0000-0002-9529-6136
Avantea · ITInserm · FRUniversity of Padua · ITCentre Hospitalier Universitaire de Nantes · FRInstitut d'Investigació Biomédica de Bellvitge · ESOniris · FRTel Aviv University · ILUniversitat Autònoma de Barcelona · ES

Funding

European Union Seventh Framework Program (FP7/2007/2013) Translink 603049
6 · The paper itself

Abstract

Two well-characterized carbohydrate epitopes are absent in humans but present in other mammals. These are galactose-α1,3-galactose (αGal) and N-glycolylneuraminic acid (Neu5Gc) which are introduced by the activities of two enzymes including α(1,3) galactosyltransferase (encoded by the GGTA1 gene) and CMP-Neu5Gc hydroxylase (encoded by the CMAH gene) that are inactive in humans but present in cattle. Hence, bovine-derived products are antigenic in humans who receive bioprosthetic heart valves (BHVs) or those that suffer from red meat syndrome. Using programmable nucleases, we disrupted (knockout, KO) GGTA1 and CMAH genes encoding for the enzymes that catalyse the synthesis of αGal and Neu5Gc, respectively, in both male and female bovine fibroblasts. The KO in clonally selected fibroblasts was detected by polymerase chain reaction (PCR) and confirmed by Sanger sequencing. Selected fibroblasts colonies were used for somatic cell nuclear transfer (SCNT) to produce cloned embryos that were implanted in surrogate recipient heifers. Fifty-three embryos were implanted in 33 recipients heifers; 3 pregnancies were carried to term and delivered 3 live calves. Primary cell cultures were established from the 3 calves and following molecular analyses confirmed the genetic deletions. FACS analysis showed the double-KO phenotype for both antigens confirming the mutated genotypes. Availability of such cattle double-KO model lacking both αGal and Neu5Gc offers a unique opportunity to study the functionality of BHV manufactured with tissues of potentially lower immunogenicity, as well as a possible new clinical approaches to help patients with red meat allergy syndrome due to the presence of these xenoantigens in the diet.

Indexed as

Animals, Genetically ModifiedGene Knockout TechniquesAnimalsAntigens, HeterophileBioprosthesisCattleCytidine MonophosphateFemaleFibroblastsFood HypersensitivityGalactoseGalactosyltransferasesHeart Valve ProsthesisHumansMaleMixed Function OxygenasesAntigens, HeterophileCMPacetylneuraminate monooxygenaseCytidine Monophosphatecytidine monophosphate-N-glycoloylneuraminic acidGalactoseGalactosyltransferasesMixed Function OxygenasesNeuraminic Acidsbioprosthetic Heart Valve (BHV)cattleCMAHGGTA1knockoutNeu5GcxenotransplantationαGal

Identifiers

PMID31115108
PMCPMC6852128
OpenAlexW2946027397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.